they are both for the same indication, CEMP is 240 million cap compare to 200M for DRTX. CEMP is 3 years from approval while DRTX soon to have NDA submitted for approval in 1Q2014. Do your math.
I have a better idea...sell both of these pieces of garbage and buy TSRX. remember Pfizer dumped dalbavancin for a reason...I mean honestly how long has DRTX's drug been in phase 3? something is wrong.
Why? Cemp went up today 10.6% and DRTX was down 9 cents.
Look at DRTX today you will know why? it is only the start, NDA in the making ...